三孚股份(603938.SH):擬註銷全資子公司三孚化學原料
格隆匯7月13日丨三孚股份(603938.SH)公佈,公司第四屆董事會第九次會議審議通過了《關於註銷全資子公司唐山三孚化學原料有限公司的議案》,公司擬註銷全資子公司唐山三孚化學原料有限公司(“三孚化學原料”)並授權經營管理層辦理相關注銷事項。
三孚化學原料系公司的全資子公司,截至公吿披露日,公司尚未對三孚化學原料實際出資,三孚化學原料無實際經營。為降低管理成本,經公司審慎研究,決定註銷該公司。
公吿顯示,此次註銷全資子公司,有助於優化公司資源配置,降低運營成本,不會對公司整體業務發展產生影響,不會損害公司及全體股東利益。註銷後,公司合併報表範圍將發生相應變化,但不會對公司合併報表產生實質影響。通合夥)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.